rs826802

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_014141.6(CNTNAP2):​c.1498+37685G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.401 in 151,950 control chromosomes in the GnomAD database, including 13,604 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.40 ( 13604 hom., cov: 32)

Consequence

CNTNAP2
NM_014141.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.368

Publications

5 publications found
Variant links:
Genes affected
CNTNAP2 (HGNC:13830): (contactin associated protein 2) This gene encodes a member of the neurexin family which functions in the vertebrate nervous system as cell adhesion molecules and receptors. This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains. In addition, it includes an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, thrombospondin N-terminal-like domains and a putative PDZ binding site. This protein is localized at the juxtaparanodes of myelinated axons, and mediates interactions between neurons and glia during nervous system development and is also involved in localization of potassium channels within differentiating axons. This gene encompasses almost 1.5% of chromosome 7 and is one of the largest genes in the human genome. It is directly bound and regulated by forkhead box protein P2, a transcription factor related to speech and language development. This gene has been implicated in multiple neurodevelopmental disorders, including Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. [provided by RefSeq, Jul 2017]
CNTNAP2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR, AD Classification: DEFINITIVE, NO_KNOWN Submitted by: ClinGen
  • cortical dysplasia-focal epilepsy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.597 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014141.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CNTNAP2
NM_014141.6
MANE Select
c.1498+37685G>T
intron
N/ANP_054860.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CNTNAP2
ENST00000361727.8
TSL:1 MANE Select
c.1498+37685G>T
intron
N/AENSP00000354778.3
CNTNAP2
ENST00000636870.1
TSL:5
n.1360+37685G>T
intron
N/A
CNTNAP2
ENST00000637694.1
TSL:5
n.1401+37685G>T
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.401
AC:
60831
AN:
151832
Hom.:
13599
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.604
Gnomad AMI
AF:
0.348
Gnomad AMR
AF:
0.385
Gnomad ASJ
AF:
0.389
Gnomad EAS
AF:
0.366
Gnomad SAS
AF:
0.252
Gnomad FIN
AF:
0.279
Gnomad MID
AF:
0.398
Gnomad NFE
AF:
0.314
Gnomad OTH
AF:
0.395
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.401
AC:
60864
AN:
151950
Hom.:
13604
Cov.:
32
AF XY:
0.396
AC XY:
29413
AN XY:
74252
show subpopulations
African (AFR)
AF:
0.604
AC:
25018
AN:
41444
American (AMR)
AF:
0.385
AC:
5876
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.389
AC:
1345
AN:
3462
East Asian (EAS)
AF:
0.365
AC:
1883
AN:
5160
South Asian (SAS)
AF:
0.252
AC:
1211
AN:
4800
European-Finnish (FIN)
AF:
0.279
AC:
2947
AN:
10566
Middle Eastern (MID)
AF:
0.387
AC:
113
AN:
292
European-Non Finnish (NFE)
AF:
0.314
AC:
21325
AN:
67940
Other (OTH)
AF:
0.393
AC:
829
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1787
3574
5361
7148
8935
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
562
1124
1686
2248
2810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.349
Hom.:
16444
Bravo
AF:
0.421
Asia WGS
AF:
0.326
AC:
1133
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
2.4
DANN
Benign
0.56
PhyloP100
0.37
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs826802; hg19: chr7-147035067; COSMIC: COSV62200129; API